eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.
advertisement
.
.
.activity
.
. tusk made his remarks about the u.s. president's reliability before he chaired a meeting in bulgaria of the 28 leaders whose countries make up the world's biggest trading bloc.
.
standard life and aviva clash over adviser charging
.
.
.
.
richard lipton, md, director, montefiore headache center; edwin s. lowe professor and vice chairman of neurology, albert einstein college of medicine.
.